Xiaoya Guan

Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Integrative Single-Cell and Spatial Transcriptomics Analysis Reveals ECM-remodeling Cancer-associated Fibroblast-Derived POSTN as a Key Mediator in Pancreatic Ductal Adenocarcinoma Progression.

Integrative Single-Cell and Spatial Transcriptomics Analysis Reveals ECM-remodeling Cancer-associated Fibroblast-Derived POSTN as a Key Mediator in Pancreatic Ductal Adenocarcinoma Progression.

Journal: International journal of biological sciences

Published: December 11, 2024

Oncogenic and Immunological Roles of FRS2 and its Potential Value in Retroperitoneal Liposarcoma: from Bioinformatics Analysis to Clinicopathological Evidence.

Oncogenic and Immunological Roles of FRS2 and its Potential Value in Retroperitoneal Liposarcoma: from Bioinformatics Analysis to Clinicopathological Evidence.

Journal: International journal of medical sciences

Published: September 17, 2024

Integrated lipidomics and RNA-seq reveal prognostic biomarkers in well-differentiated and dedifferentiated retroperitoneal liposarcoma.

Integrated lipidomics and RNA-seq reveal prognostic biomarkers in well-differentiated and dedifferentiated retroperitoneal liposarcoma.

Journal: Cancer cell international

Published: February 01, 2024

Combination of eribulin and anlotinib exerts synergistic cytotoxicity in retroperitoneal liposarcoma by inducing endoplasmic reticulum stress.

Combination of eribulin and anlotinib exerts synergistic cytotoxicity in retroperitoneal liposarcoma by inducing endoplasmic reticulum stress.

Journal: Cell death discovery

Published: December 28, 2023

Identification of the γ-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing pancreatic cancer.

Identification of the γ-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing pancreatic cancer.

Journal: Annals of medicine

Published: August 06, 2023

Differential analysis of core-fucosylated glycoproteomics enabled by single-step truncation of N-glycans.

Differential analysis of core-fucosylated glycoproteomics enabled by single-step truncation of N-glycans.

Journal: Glycoconjugate journal

Published: April 07, 2023

Expression and function of Siglec-15 in RLPS and its correlation with PD-L1: Bioinformatics Analysis and Clinicopathological Evidence.

Expression and function of Siglec-15 in RLPS and its correlation with PD-L1: Bioinformatics Analysis and Clinicopathological Evidence.

Journal: International journal of medical sciences

Published: July 16, 2022

Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.

Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.

Journal: International journal of medical sciences

Published: January 03, 2022

Tsp2 Facilitates Tumor-associated Fibroblasts Formation and Promotes Tumor Progression in Retroperitoneal Liposarcoma.

Tsp2 Facilitates Tumor-associated Fibroblasts Formation and Promotes Tumor Progression in Retroperitoneal Liposarcoma.

Journal: International journal of biological sciences

Published: December 15, 2021

Anti-Tumor Effect of Apatinib and Relevant Mechanisms in Liposarcoma.

Anti-Tumor Effect of Apatinib and Relevant Mechanisms in Liposarcoma.

Journal: Frontiers in oncology

Published: July 10, 2021

Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.

Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.

Journal: Frontiers in oncology

Published: October 16, 2020

CD26 as a Promising Biomarker for Predicting Prognosis in Patients with Pancreatic Tumors.

CD26 as a Promising Biomarker for Predicting Prognosis in Patients with Pancreatic Tumors.

Journal: OncoTargets and therapy

Published: August 30, 2020

Showing 1-12 of 24

Last Updated: 09/26/2026